Research Article | DOI: https://doi.org/10.31579/2690-4861/858
1 (House officer), Faculty of medicine, ASSAFA College, Khartoum, Sudan.
2 (GP), Faculty of Medicine and Surgery, Shendi University, Shendi, Sudan.
3 (House officer), Omdurman Islamic University, Faculty of Medicine and Health Science, Omdurman, Sudan.
4 (House Officer), Faculty of Medicine and Surgery. National University Khartoum, Sudan.
5 (House Officer), Faculty of Medicine, Elrazi University, Khartoum, The Republic of the Sudan.
6 (General Practitioner), Faculty of Medicine, University of Bahri, Khartoum, Sudan.
7 (House Officer), Gezira College of Medical sciences and Technology, Wad Medani, Sudan.
8 (GP), School of Medicine, Ahfad University for Women, Omdurman, Sudan.
9 (Professor), Head of the Chest Diseases Department, Aswan University Hospital, Aswan, Egypt.
*Corresponding Author: Fatima Elmahi Ahmed Elkhalifa, (House officer) Faculty of medicine, ASSAFA College, Khartoum, Sudan.
Citation: Ahmed Elkhalifa FE, Khalid Mohammed AH, Abdalla Mohamed OM, Haghassan Osman AK, Osman Seedahmed RA, et al., (2025), Approach and Management of Acute Bronchial Asthma Exacerbation at Aswan University Hospital, International Journal of Clinical Case Reports and Reviews, 28(3); DOI:10.31579/2690-4861/858
Copyright: © 2025, Fatima Elmahi Ahmed Elkhalifa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 04 August 2025 | Accepted: 11 August 2025 | Published: 21 August 2025
Keywords: mmunosuppression; cancer immunotherapy; myeloid-derived suppressor cells (MDSC); cancer cachexia; immunosuppressive cells
Asthma is a respiratory disease characterized by recurrent episodes of dyspnea, cough, and wheeze caused by reversible airways obstruction. Histological examination of the airway tissue in an asthmatic lung shows the presence of an inflammatory reaction, with extensive remodeling of the airway wall. The inflammation is a multicellular process; even in the mildest of asthmatic individuals there is in vivo evidence of infiltration of the bronchial mucosa with mast cells, mononuclear cells, and granulocytes, of which the eosinophil is prominent
Asthma is a respiratory disease characterized by recurrent episodes of dyspnea, cough, and wheeze caused by reversible airways obstruction. [1] Histological examination of the airway tissue in an asthmatic lung shows the presence of an inflammatory reaction, with extensive remodeling of the airway wall. The inflammation is a multicellular process; even in the mildest of asthmatic individuals there is in vivo evidence of infiltration of the bronchial mucosa with mast cells, mononuclear cells, and granulocytes, of which the eosinophil is prominent. [2] The tenacious plugs that fill the lumen are an exudate of plasma and inflammatory cells, particularly eosinophils, which have migrated into the lumen, as well as epithelial cells that have sloughed from the airway surface, often leaving the basement membrane denuded. The basement membrane appears thickened when viewed under the light microscope, which is due to an increase in the amount of collagen deposition at this site, but the lamina densa, which forms the true basement membrane, is normal when observed with the electron microscope. [3] The changes in the lumen and wall of the airways of asthmatic lungs are reflected in the cytological examination of sputum from patients with the disease. There is a clear increase in wall thickness throughout the bronchial tree in patients with asthma, and all the tissue layers participate in this generalized increase in airway wall thickness. [4] Asthma exacerbations are episodes of progressively worsening airway narrowing, associated with increasing shortness of breath, cough, wheezing, chest tightness, or some combination of these. [5] Exacerbations can vary in severity from episodes which patients are able to manage themselves by following an agreed treatment plan, to severe and potentially life-threatening episodes that require medical attention and hospital admission. Severe attacks also vary in their speed of onset, ranging from deterioration over days to episodes that progress rapidly and can become life-threatening within minutes or hours.[6] The aims of the treatment of acute severe asthma are to reverse the hypoxia, airflow limitation, and airway inflammation with oxygen, bronchodilators, and corticosteroids.
By conducting this clinical audit, we aim to enhance the overall quality of hospital care for patients with acute asthma, promote adherence to best practices, and improve patient outcomes.
Standard
The initial assessment criteria in all patients with acute asthma exacerbation are respiratory rate, heart rate, oxygen saturation, peak expiratory flow rate (PEFR), severity of exacerbation, and identified potential trigger. The standard was set to be 100% for each criterion. Based on GINA guidelines, the treatment criteria for all patients with acute asthma exacerbation are administration of short acting beta agonist "SABA" as needed based on the severity and weight, administration of inhaled corticosteroids (ICS) at appropriate dose based on severity and weight, administration of oxygen therapy if the saturation below 90% or in evidence of respiratory distress, administration of additional therapies (like magnesium sulfate, and nebulized heliox) in case of worsening asthma, mechanical ventilation and intensive care unit (ICU) admissions in severe cases. The standard was set to be 100% for each criterion.
Regarding monitoring and evaluation criteria in all patients with acute asthma exacerbation, they are vital signs monitored regularly (every 30 minutes or as needed), response to treatment assessed regularly (every 30 minutes or as needed), treatment plan adjusted based on treatment response, and patient education about self-management and inhalers techniques. The standard was set to be 100% for each criterion.
Regarding the first cycle, a retrospective study was done. The sample size was 40 staff members (doctors) who approached and managed patients with bronchial asthma exacerbations in chest emergency department and different departments. The sampling technique was total sampling so no one was excluded. Data were collected by a self-administrated questionnaire to evaluate staff awareness and adherence to management protocols (GINA guidelines), and analyzed by SPSS version 27.0. and Excel sheet.
The percentage of medical staff in chest emergency department from the hospital departments was 80% [figure-1].

Figure-1. Percentage of staff members according to their department.
The majority of them with 6 – 9 months experience in chest emergencies [figure-2]. Regarding the initial assessment data, the results were 87%, 87%, 97%, 17%, 56%, and 97% for respiratory rate, heart rate, oxygen saturation, peak expiratory flow rate (PEFR), severity of exacerbation, and identification of the trigger from history, respectively.

Figure-2. Period of time the staff member has been working in the hospital (in Months).
In terms of treatment administration and monitoring and evaluation, the data are presented in the tables [table-1] and [table-2].
| Criteria | Standard | First cycle standard |
| Administration of Short-acting Beta Agonist (SABA) as needed based on severity and weight | 100% | 85% |
| Administration of Inhaled Corticosteroids (ICS) at appropriate dose based on severity and weight | 100% | 87% |
| Administration of Short-acting Anticholinergic (Ipratropium Bromide) according to appropriate dose. | 100% | 55% |
| Administration of Systemic Corticosteroids (Oral, IV) according to weight | 100% | 72% |
| Administration of Oxygen Therapy if saturation is below 90%, or in evidence of respiratory distress | 100% | 46% |
| Administration of additional therapies (e.g. Magnesium Sulphate, Nebulized Heliox) in case of worsening asthma | 100% | 85% |
| Mechanical Ventilation and ICU admissions in severe cases. | 100% | 95% |
Table 1: Treatment criteria for all patients with acute asthma exacerbation
| Criteria | Standard | First cycle standard |
| Vital signs monitored regularly (every 30 minutes or as needed) | 100% | 25% |
| Response to treatment assessed regularly (every 30 minutes or as needed) | 100% | 92% |
| Patient education about self-management and inhalers techniques | 100% | 72% |
| Personalized discharge plans initiated prior to discharge | 100% | 87% |
| Follow-up appointment scheduled after discharge | 100% | 62% |
Table 2: Monitoring and evaluation criteria in all patients with acute asthma exacerbation 67% of doctors believe the hospital’s protocol of asthma exacerbation management is effective. So agreed changes were implemented for the staff and system, which were.
Training sessions in asthma exacerbation management.
Cognitive scheme to remember items of management.
To make sure the prescription is written in clear and informative way.
Continuous monitoring of each patient condition until its safely managed.
Develop patient centered discharge plan with clear instructions on medication use and follow up.
Asthma classification and management posters.
Asthma approach and management assessment checklist paper for each patient.
Provide sufficient drugs and equipment for rapid interference and management like peak expiratory flow rate meter device.
Recommendation And Quality Improvement Plan
The improvement strategies suggested by staff members to enhance management of asthma exacerbation were implement a standardized triage system to identify patients at risk rapidly, provide adequate drugs and equipment for rapid interference and management, implementation of od regular training programs for the staff, and developing patient-centered discharge plans with clear instructions on medication use and follow up.
The percentage of medical staff in chest emergency department from the hospital departments was 80% [figure-1].

The majority of them with 6 – 9 months experience in chest emergencies [figure-2]. Regarding the initial assessment data, the results were 87%, 87%, 97%, 17%, 56%, and 97% for respiratory rate, heart rate, oxygen saturation, peak expiratory flow rate (PEFR), severity of exacerbation, and identification of the trigger from history, respectively.

In terms of treatment administration and monitoring and evaluation, the data are presented in the tables [table-1] and [table-2].
| Criteria | Standard | First cycle standard |
| Administration of Short-acting Beta Agonist (SABA) as needed based on severity and weight | 100% | 85% |
| Administration of Inhaled Corticosteroids (ICS) at appropriate dose based on severity and weight | 100% | 87% |
| Administration of Short-acting Anticholinergic (Ipratropium Bromide) according to appropriate dose. | 100% | 55% |
| Administration of Systemic Corticosteroids (Oral, IV) according to weight | 100% | 72% |
| Administration of Oxygen Therapy if saturation is below 90%, or in evidence of respiratory distress | 100% | 46% |
| Administration of additional therapies (e.g. Magnesium Sulphate, Nebulized Heliox) in case of worsening asthma | 100% | 85% |
| Mechanical Ventilation and ICU admissions in severe cases. | 100% | 95% |
Table 1: Treatment criteria for all patients with acute asthma exacerbation
| Criteria | Standard | First cycle standard |
| Vital signs monitored regularly (every 30 minutes or as needed) | 100% | 25% |
| Response to treatment assessed regularly (every 30 minutes or as needed) | 100% | 92% |
| Patient education about self-management and inhalers techniques | 100% | 72% |
| Personalized discharge plans initiated prior to discharge | 100% | 87% |
| Follow-up appointment scheduled after discharge | 100% | 62% |
Table 2: Monitoring and evaluation criteria in all patients with acute asthma exacerbation 67% of doctors believe the hospital’s protocol of asthma exacerbation management is effective. So agreed changes were implemented for the staff and system, which were.
Training sessions in asthma exacerbation management.
Cognitive scheme to remember items of management.
To make sure the prescription is written in clear and informative way.
Continuous monitoring of each patient condition until its safely managed.
Develop patient centered discharge plan with clear instructions on medication use and follow up.
Asthma classification and management posters.
Asthma approach and management assessment checklist paper for each patient.
Provide sufficient drugs and equipment for rapid interference and management like peak expiratory flow rate meter device.
Recommendation And Quality Improvement Plan
The improvement strategies suggested by staff members to enhance management of asthma exacerbation were implement a standardized triage system to identify patients at risk rapidly, provide adequate drugs and equipment for rapid interference and management, implementation of od regular training programs for the staff, and developing patient-centered discharge plans with clear instructions on medication use and follow up.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,